Skip to main content
SpringerLink
Log in

Meningococcal B vaccine to be introduced in the UK

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • , et al. Meningococcal B vaccine to be introduced in UK. PharmacoEconomics and Outcomes News : 12, Mar 2014

  • , et al. JCVI position statement on use of Bexsero? meningococcal B vaccine in the UK Internet Document : 25 Mar 2014. Available from: URL: https://www.gov.uk

  • Novartis. UK recommends Novartis Bexsero(Rm) vaccine for inclusion in National Immunisation Programme to help protect against devastating meningitis B. Media Release : 21 Mar 2014. Available from: URL: http://www.novartis.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Meningococcal B vaccine to be introduced in the UK. PharmacoEcon Outcomes News 700, 12 (2014). https://doi.org/10.1007/s40274-014-1182-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-014-1182-7

Search

Navigation